#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Thyroid cancer metastatic Waldenstrom's macroglobulinaemia Microscopic polyangiitis Heart disease congenital Behcet's syndrome Erythema multiforme Duchenne muscular dystrophy Factor VIII deficiency Extra-osseous Ewing's sarcoma Thymic carcinoma Non-small cell lung cancer PIK3CA related overgrowth spectrum Palmoplantar pustulosis Henoch-Schonlein purpura Autoinflammation with infantile enterocolitis More trials…

    Learn about Rare Diseases

    Castleman’s disease Urea cycle disorder – Diagnostics Glycogen storage disease type V – Life with Disease Idiopathic inflammatory myopathy – Treatment Retinitis pigmentosa – Treatment Tuberous sclerosis complex – Life with Disease Congenital nephrogenic diabetes insipidus – Diagnostics Wiskott-Aldrich syndrome – Diagnostics Glomerulonephritis membranoproliferative MELAS syndrome – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Follitropin Delta Remifentanil Chlorhexidine Gluconate [99MTC]PSMA I&S Betamethasone Valerate Df1001 Tovorafenib Ulotaront Falbikitug Telitacicept Metamizole Magnesium Nadunolimab Sacituzumab Govitecan Ianalumab Tozinameran Mebendazole POLYSORBATE 80 Bi 3720931 Liraglutide Gfh925 More therapies…

    Learn about Your Condition

    Hidradenitis Plasma cell leukaemia Myotonia Post-traumatic stress disorder Wiskott-Aldrich syndrome Herpes zoster Paraganglion neoplasm Triple negative breast cancer Oesophagogastroscopy Oxygen therapy Amyloidosis Transplantation complication Tertiary adrenal insufficiency Langerhans cell sarcoma Idiopathic pulmonary fibrosis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. NZOZ Neuro- Kard Ilkowski i Partnerzy Spółka Partnerska…

NZOZ Neuro- Kard Ilkowski i Partnerzy Spółka Partnerska Lekarzy

Ul. Wierzbowa 2/2, Poznan, 61-853, Poland

Want to learn more about this study or check if you can participate? Contact us.

  • Study of Telitacicept for Treating Generalized Myasthenia Gravis in Patients

    Recruiting

    3 1
    Investigated Drugs:
    • Telitacicept
    Belgium Bulgaria Czechia Denmark France Italy +2

  • AUR200 for Patients with Generalized Myasthenia Gravis

    Recruiting

    1 1 1
    Investigated Drugs:
    • AUR200
    • Sodium Chloride
    Poland

  • Study on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History

    Recruiting

    3 1
    Investigated Diseases:
    • Acute myocardial infarction
    Investigated Drugs:
    • Selatogrel
    Austria Belgium Bulgaria Croatia Czechia Denmark +17

  • Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Relapsing-remitting multiple sclerosis
    Investigated Drugs:
    • Ocrelizumab
    Belgium Bulgaria Croatia Czechia Denmark France +9

  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +15

  • Phase III Study of the Efficacy and Safety of Fenebrutinib Compared with Teriflunomide in Adult Patients with Relapsing Multiple Sclerosis

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Fenebrutinib
    • Teriflunomide
    Austria Bulgaria Denmark France Greece Italy +1

  • A Study of Donanemab in People With Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia
    • Mental disorder
    • Neurodegenerative disorder
    Investigated Drugs:
    • Donanemab
    • Florbetapir (18F)
    • Flortaucipir (18F)
    Poland Spain

  • Study on LY3848575 for Reducing Pain in Patients with Distal Sensory Polyneuropathy

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Neuralgia
    • Polyneuropathy
    Investigated Drugs:
    • LY3848575
    Germany Poland

  • Study on Masitinib for Treating Primary or Secondary Progressive Multiple Sclerosis in Patients Without Relapse

    Not recruiting

    3 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Masitinib
    France Greece Poland Spain

  • Study on the Safety and Effects of LY3372689 in Patients with Early Alzheimer’s Disease

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • N-[4-Fluoro-5-[[2S,4S)-2-Methyl-4-[(5-Methyl-1,2,4-Oxadiazol-3-Yl)Methoxy]-1-Piperidinyl]Methyl]-2-Thiazolyl-Acetamide
    • Flortaucipir (18F)
    Poland
Previous Page
1 2 3 4
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!